Ginkgo Bioworks Holdings (DNA) Amortization of Goodwill (2024)

Ginkgo Bioworks Holdings (DNA) posted Amortization of Goodwill of $47.9 million for Q2 2024.

Ginkgo Bioworks Holdings (DNA) Amortization of Goodwill (2024) Analysis & Trends

Ginkgo Bioworks Holdings' Amortization of Goodwill history runs 1 years deep, the most recent figure standing at $47.9 million for Q2 2024.

  • Quarterly Amortization of Goodwill changed N/A year-over-year to $47.9 million in Q2 2024, while the trailing twelve-month figure through Jun 2025 was $47.9 million (changed 0.0% YoY) and the FY2024 annual result came in at $47.9 million, changed N/A from the prior year.
  • Amortization of Goodwill was $47.9 million for Q2 2024 at Ginkgo Bioworks Holdings.
  • Across five years, Amortization of Goodwill topped out at $47.9 million in Q2 2024 and bottomed at $47.9 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Ginkgo Bioworks Holdings 517.16 Mn 373.30 Mn 16.38 Mn

Historic Data

Download Data
DateValue
Jun 30, 2024 47.90 Mn
Jun 30, 2024 47.90 Mn